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Herpes simplex virus type 1 (HSV-1) specifies at least 12
glycoproteins, gB, gC, gD, gE, gG, gH, gI, gJ, gK, gL, gM, and
gN, that are expressed during a productive viral infection.
These glycoproteins function in pH-independent virus entry
via fusion of the viral envelope with cellular membranes, cellto-cell spread, egress of infectious virion particles, and virusinduced cell-to-cell fusion. (26, 37, 42, 43). Mutations that
cause extensive virus-induced cell fusion, syncytia, can arise in
at least four different regions of the viral genome, including the
UL20 gene (1, 24), the UL24 gene (20, 39), the UL27 gene
encoding glycoprotein B (gB) (5, 30), and the UL53 gene
coding for glycoprotein K (gK) (2, 7, 32, 38). However, syncytial mutations (syn) in the UL53 (gK) gene are more frequently
isolated than syncytium mutations in any other genes (2, 3, 7,
8, 32, 33, 35, 38).
HSV-1 gK is encoded by the UL53 open reading frame
(ORF) (7, 25), and it has characteristics of a glycosylated
membrane protein, including an N-terminal signal sequence,
two potential sites for N-glycosylation 10 amino acids apart (7,
33), and several hydrophobic domains (7). Antisera generated
in rabbits against gK-specific peptides indicated that gK exists
as a single 40-kDa protein species in infected cells (17). In
contrast, gK translated in vitro had an apparent molecular
mass of 36 kDa, and N-linked glycosylation occurred in the first
112 residues of the protein, consistent with glycosylation at
amino acids 48 and 58 (34). Initially, gK was predicted to have
four transmembrane regions (7); however, experiments with in
vitro-translated gK in the presence of microsomal membranes
suggested that gK contained three instead of four membrane-
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spanning regions (27). This topological orientation placed all
syn mutations within the proposed ectodomains of gK (10, 27).
Mutants that are deficient in gK expression have been isolated and characterized for several alphaherpesviruses. These
studies have indicated that gK is important in virion morphogenesis and egress (10, 18, 21, 22, 28). Deletion of gK resulted
in a small-plaque phenotype, reduced virus yield, and a restriction in the ability of virus to be translocated from the cytoplasm to the extracellular space. Moreover, at least for pseudorabies virus (PRV), there appeared to be a role for gK in
preventing reinfection of cells (22).
Despite the established role of gK in membrane fusion,
initial characterization of gK localization indicated that HSV-1
gK was retained within the endoplasmic reticulum (ER) and
nuclear membranes (19). The inability of gK to be transported
to the Golgi complex and, subsequently, to cell surfaces complicated the elucidation of the role gK could play in mediating
cell-to-cell fusion. Furthermore, contrary to studies with other
alphaherpesviruses, including PRV and varicella-zoster virus
(VZV) (22, 28), HSV-1 gK was thought not to be a structural
component of virion particles (19). The absence of gK from
virions was difficult to reconcile with studies that had indicated
that HSV-1 virions which specified mutations in gK exhibited
delayed entry kinetics (31). Due to limitations in the ability of
gK peptide antisera to detect HSV-1 gK, we generated recombinant viruses that specified protein C (protC) epitope tags
within gK. Here we show that HSV-1 gK, like gK of other
alphaherpesviruses, is a structural component of purified virions. Moreover, gK exists on purified virions and within cells as
a Golgi complex-dependent glycosylated species.
Construction and characterization of HSV-1 recombinant
virus gKprotC-DIII expressing gK containing an in-frame insertion of a 12-amino-acid protC tag. Over the past 20 years,
different laboratories have attempted to generate monospecific
antibodies and monoclonal antibodies (MAbs) against gK to
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To facilitate detection of glycoprotein K (gK) specified by herpes simplex virus, a 12-amino-acid epitope tag
was inserted within gK domain III. Recombinant virus gKprotC-DIII, expressing the tagged gK, was isolated.
This virus formed wild-type plaques and replicated as efficiently as the wild-type KOS virus in Vero cells.
Anti-protein C MAb detected high-mannose and Golgi complex-dependent glycosylated gK within cells as well
as on purified virions. The gK-null virus ⌬gK (gKⴚ/ⴚ) entered Vero cells substantially more slowly than the
wild-type KOS (gKⴙ/ⴙ), while ⌬gK virus grown in complementing VK302 cells (gKⴚ/ⴙ) entered with entry
kinetics similar to those of the KOS virus.
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facilitate its detection. To improve detection of gK, the 12amino-acid protein C-derived epitope tag was inserted inframe within gK domain III at a site predicted not to significantly affect the secondary structure of gK (Fig. 1D). The
recombinant gK gene coding for the epitope-tagged gK was
constructed using PCR-based splice-overlap extension methodology as described previously (6, 10, 11) and cloned into
plasmid pSJ1723, generating plasmid pTF9301 (Fig. 1C). This
plasmid contained gK-flanking sequences corresponding to the
UL52 and UL54 (ICP27) genes to facilitate homologous recombination with viral DNA (21). Recombinant virus gKprotC-DIII was constructed by rescuing the mutant virus d271(KOS) (36), which has a lethal deletion within the UL54 gene
specifying the immediate-early protein ICP27 as shown previously (9, 10, 21) (Fig. 1A to C). Putative recombinant virus
isolates were plaque purified and tested by PCR and DNA
sequencing for the presence of contaminating d27-1 virus and
the engineered epitope-tagged gK (not shown).
For analysis of virus spread and replication, Vero cells were
infected with serial dilutions of wild-type HSV-1 (KOS) and
gKprotC-DIII viruses, overlaid with medium containing 1%
methyl cellulose, and incubated at 37°C for 48 h. Viral plaques
were visualized by phase-contrast microscopy and photographed. Recombinant virus gKprotC-DIII produced viral
plaques that were morphologically similar to KOS plaques
(Fig. 2A and B).
For analysis of one-step growth kinetics, each virus at a
multiplicity of infection (MOI) of 5 was adsorbed to approximately 8 ⫻ 105 Vero cells at 4°C for 1 h. Thereafter, warm
medium was added, and virus was allowed to penetrate for 2 h
at 37°C. Any remaining extracellular virus was inactivated by
low-pH treatment (0.1 M glycine, pH 3.0). Cells and supernatants were harvested immediately (0 h) or after 4, 8, 12, 20, 30,
or 48 h of incubation. Virus titers were determined by titration
on Vero cells. The gKprotC-DIII virus replicated as efficiently
as the KOS parental strain in Vero cells (Fig. 2C). These
results indicated that insertion of the 12-amino-acid protC
epitope tag within gK domain III did not adversely affect the
structure and function of gK with regard to virus replication
and cell-to-cell spread.
Detection and characterization of gK specified by gKprotCDIII using anti-protC MAb. Subconfluent Vero cell monolayers were infected with either gKprotC-DIII or KOS at an MOI
of 5. Forty-eight hours postinfection, cells were collected by
low-speed centrifugation, washed with Tris-buffered saline
(TBS), and lysed at room temperature for 15 min in mammalian protein extraction reagent (MPER) supplemented with a
cocktail of protease inhibitors (Invitrogen-Life Technologies,
Carlsbad, Calif.). Insoluble cell debris was pelleted, and samples were electrophoretically separated by sodium dodecyl sul-
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fate–10% polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred to nitrocellulose membranes (9). Blots were
probed overnight with anti-protC MAb HPC-4 at 1:50 dilution
(ATCC CRL HB-9892). Subsequently, blots were incubated
for 1 h with a peroxidase-conjugated secondary antibody at a
1:50,000 dilution and visualized on x-ray film by chemiluminescence (Pierce Chemical, Rockford, Ill.) (9, 12). All antibody
dilutions and buffer washes were performed in TBS supplemented with 0.135 M CaCl2 and 0.11 M MgCl2.
MAb HPC-4 detected gK protein species ranging from approximately 36 to 43 kDa, with the predominant species migrating with an apparent molecular mass of approximately 36
kDa. Additional minor protein species were detected with molecular masses ranging from 36 to 43 kDa, as well as a protein
species with an apparent molecular mass of 25 kDa. In contrast, antibody HPC-4 did not react against extracts derived
from KOS-infected cells (Fig. 3A). Similar to other herpesvirus
glycoproteins, these results show that the protC-tagged gK
exists as multiple protein species in virus-infected cell extracts.
The predicted molecular mass of the unglycosylated gK protein backbone (308 amino acids after signal peptide cleavage)
is approximately 31 kDa; however, after addition of the protC
tag, the molecular mass should be approximately 32.5 kDa.
Thus, the gK-related species with molecular masses of 36 to 43
kDa represent glycosylated gK derivatives. The 25-kDa protein
could be either a proteolytically processed peptide or a previously predicted gK-related protein, which may be produced by
an alternate transcript utilizing an initiation codon within the
UL53 ORF (29).
Previous investigations have shown that HSV-1 gK contained N-linked carbohydrate species (17, 34). To characterize
the carbohydrate character of gK, Vero cell monolayers were
infected with gKprotC-DIII at an MOI of 5 and incubated in
the presence or absence of 5 g of tunicamycin (TM) per ml.
Cellular extracts were prepared at 48 h postinfection and analyzed by SDS-PAGE and immunoblot analysis using either
anti-protC antibody, HPC-4, or anti-gD antibody 1103 (Rumbaugh-Goodwin Institute, Plantation, Fla.) (Fig. 3C). In the
presence of TM, gK had an apparent molecular mass of approximately 32 kDa, which corresponded to the predicted molecular mass of the unglycosylated gK after removal of the
signal peptide (Fig. 3C, lanes 1 and 2). As a control, a parallel
blot was incubated with anti-gD antibody (1:2,000). As expected, TM reduced the apparent molecular mass of gD from
59 to 50 kDa (Fig. 3C, lanes 3 and 4) (41).
To further investigate the glycosylation of gK, infected cellular extracts were mock treated or incubated in the presence
of either endoglycosidase H (Endo-H) or peptide:N-glycosidase F (PNGase F). N-linked carbohydrates were removed
from proteins contained within infected cell lysates by a mod-

FIG. 1. Construction of recombinant virus gKprotC-DIII, specifying gK containing a protein C epitope tag. (A) The top line represents the
prototypic arrangement of the HSV-1 genome with the unique long (UL) and unique short (US) regions flanked by the terminal repeat (TR) and
internal repeat (IR) regions. (B) Shown below is the region of the mutant virus HSV-1 d27-1 genome (between map units 0.7 and 0.8) containing
the UL52, UL53, and the partially deleted UL54 open reading frames (shaded and boxed regions of the UL54 gene pointed to by an arrow) with
relevant restriction endonuclease sites. (C) Plasmid construct, pTF9301, containing the recombinant gK-protC gene and flanking UL52 and UL54
sequences used to generate recombinant virus gKprotC-DIII. (D) Schematic model of the predicted secondary structure of gK (10). The predicted
putative hydrophobic domains (hpd) of gK that transverse the membrane are shown embedded within the membrane. The arrow points to the site
of the protC epitope tag insertion. The primary structure of the epitope tag is shown. Known syncytial mutations are denoted by asterisks.
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FIG. 2. Comparison of plaque morphology and replication characteristics of gKprotC-DIII and KOS viruses. Comparison of virus plaque
morphologies formed on Vero cells at 48 h postinfection. (A) KOS. (B) gKprotC-DIII. (C) Time-dependent kinetics of infectious virus production
after infection of Vero cells at an MOI of 5 and incubation at 37°C. The graph depicts one of three separate experiments with similar results. Each
separate experiment was repeated in triplicate to obtain standard deviations.

ified protocol of the manufacturer’s instructions and essentially
as described previously (22). Briefly, virally infected cells were
lysed at 42°C for 1 h in MPER that contained a protease
inhibitor cocktail, 0.5% SDS, and 1% ␤-mercaptoethanol.
Samples were subsequently incubated for 18 h at 42°C either

with 50 mM sodium citrate (pH 5.5) and 100 U of Endo-H
(NEB Labs, Beverly, Mass.) for Endo-H digestions, with 50
mM sodium phosphate (pH 7.5), 1% NP-40, and 20 U of
PNGase-F (NEB Labs) for PNGase-F digestions, or without
enzyme prior to SDS-PAGE and Western blot analysis.

FIG. 3. Characterization of synthesis and processing of protC-tagged gK specified by gKprotC-DIII. Immunoblots of gKprotC-DIII- (lanes 1
to 3) and KOS (lanes 4 to 6)-infected cell extracts reacted with either anti-protC MAb HPC-4 (A) or anti-gD MAb 1103 (B). Cellular extracts were
treated with Endo-H (lanes 2 and 5), PNGase-F (lanes 3 and 6), or mock treated (lanes 1 and 4). (C) Cellular extracts obtained from Vero cells
infected with gKprotC-DIII in the presence (lanes 2 and 4) or absence (lanes 1 and 3) of TM were probed with either anti-protC MAb (lanes 1
and 2) or anti-gD MAb (lanes 3 and 4).
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FIG. 4. Detection and characterization of protC-tagged gK expressed on purified virions. Immunoblots of gKprotC-DIII (lanes 1 to 3) or KOS
(lanes 4 to 6) purified virion preparations reacted with anti-protC MAb HPC-4 (A), anti-gD MAb 1103 (B), and anti-ICP27 MAb 1113 (C). Purified
virion preparations were treated with Endo-H (lanes 2 and 5), PNGase-F (lanes 3 and 6), or mock treated (lanes 1 and 4). (D) Cellular extracts
from Vero cells infected with either gKprotC-DIII (lanes 1 to 3) or KOS (lanes 4 to 6) were reacted with anti-ICP27 MAb. Cellular extracts were
treated with Endo-H (lanes 2 and 5), PNGase-F (lanes 3 and 6), or mock treated (lanes 1 and 4).

PNGase-F treatment, which cleaves off all N-linked carbohydrate chains from the protein backbone, reduced the apparent molecular mass of gK from 36 to 32 kDa (Fig. 3A, lane 3),
in agreement with gK produced in the presence of TM (Fig.
3C, lane 2). Endo-H treatment, which is specific for digestion
of high-mannose carbohydrate chains, resulted in the production of multiple protein species migrating with apparent molecular masses of 36, 34, 32, and 25 kDa. The 34-kDa band was
the predominant species, indicating that the majority of gK
expressed in infected cells contains high-mannose carbohydrate chains (Fig. 3A, lane 2). As controls for the PNGase F
and Endo-H activities, the effect of these enzymes on gD specified by either gKprotC-DIII or KOS was also assessed. Both
enzymes reduced the apparent molecular mass of gD similar to
the reduction exhibited by gK, confirming that gD contains
N-linked carbohydrates and that gD is present as both EndoH-sensitive and Endo-H-resistant forms (Fig. 3B). These results are consistent with previous reports that suggested gK is
expressed predominantly as a high-mannose glycosylated spe-

cies (19). However, a portion of the expressed gK was Endo-H
resistant even after an 18-h incubation with a high concentration of Endo-H, demonstrating that gK is transported to the
Golgi apparatus and undergoes further processing of the highmannose precursor carbohydrate moieties.
gK is a structural component of purified virions. Previous
reports suggested that HSV-1 gK might not be a structural
component of virions (19). However, studies with PRV and
VZV demonstrated that gK was present in purified virions. To
ascertain whether gK was a structural component of HSV-1
virions, we investigated whether gK specified by gKprotC-DIII
could be detected in purified virions.
KOS and gKprotC-DIII virions derived from infected Vero
cell supernatants were purified by two consecutive sucrose
density gradients as described previously (15, 16, 23). Specifically, roller bottles of Vero cells were infected at an MOI of 0.1
PFU/cell. Forty-eight hours postinfection, supernatants containing extracellular virus were harvested, and cellular debris
was removed by centrifugation at 10,000 ⫻ g for 15 min. Virus
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FIG. 5. Penetration kinetics of KOS and ⌬gK viruses into VK302 (Vero) cells. The penetration kinetics of KOS virus grown on Vero cells and
⌬gK virus grown on either Vero or VK302 cells were obtained by determining the percentage of PFU surviving low-pH treatment relative to
PBS-treated controls at different times postadsorption. Mean values and standard deviations of three independent experiments are shown.

was concentrated by pelleting through a 10% sucrose–TBS
cushion at 100,000 ⫻ g for 1.5 h. Virus pellets were resuspended in TBS, layered onto a 60 to 10% continuous sucrose
gradient, and sedimented at 100,000 ⫻ g for 2 h. Purified virus
was collected from the light-scattering phase midway through
the gradient, diluted threefold in TBS, and layered on a 10%–
30%–60% sucrose–TBS discontinuous step gradient. Purified
virion preparations were collected by side puncture at the
30%–60% interface, diluted in 30 ml of TBS, layered onto a
10% sucrose–TBS cushion, and centrifuged at 100,000 ⫻ g for
1.5 h to concentrate the virion preparations. Viral proteins
were extracted and processed in MPER-protease inhibitor
cocktail as described for cell lysates.
Antibody HPC-4 detected gK in gKprotC-DIII purified virions, while it did not react with KOS purified virions (Fig. 4A).
Treatment of purified virions with PNGase-F caused the appearance of a gK species migrating as a 32-kDa band similar to
that observed in PNGase-F-treated cellular extracts (compare
Fig. 3A, lane 3, and Fig. 4A, lane 3). The 25-kDa species
observed in cellular extracts was not detected in immunoblots
of purified virion preparations. In contrast to the results obtained with Endo-H treatment of infected cellular extracts, the
majority of gK detected in purified virions was resistant to
enzymatic digestion, indicating that it contained peripheral
sugars added at the Golgi apparatus (Fig. 4A, lane 2).
For control purposes, parallel immunoblots were assayed for
the presence of gD and ICP27. As expected, gD specified by
KOS and gKprotC-DIII virions was found to contain N-linked,

Golgi complex-dependent sugars (Fig. 4B). HSV-1 (UL54)
ICP27 is a known nonstructural protein, which is expressed in
infected cells but is not present in purified virions (45). As
expected, ICP27 was detected in gKprotC-DIII- and KOSinfected cell extracts using anti-ICP27 antibody 1113 (Rumbaugh-Goodwin Institute); however, it was not present in purified virions (Fig. 4C and D).
HSV-1 gK enhances virion entry. Based on the finding that
gK was present in purified virions and the fact that syncytium
mutations in gK alter virus entry kinetics (31) as well as cause
substantial virus-induced membrane fusion (2, 8), we examined
the penetration kinetics of the ⌬gK virus in comparison to its
parental strain, KOS. Subconfluent monolayers of VK302 cells
in six-well culture dishes were infected at 4°C for 1 h with
approximately 300 PFU of KOS or ⌬gK grown in either Vero
(gK⫺/⫺) or VK302 (gK⫺/⫹) cells. The inoculum was subsequently removed, warm medium (34°C) was added, and the
cultures were shifted to 34°C to allow virus penetration. Immediately thereafter (0 h) and at 30, 60, 120, and 180 min,
remaining extracellular virus was inactivated by treatment with
low-pH buffer (0.1 M glycine, pH 3.0). Cells were washed three
times with phosphate-buffered saline (PBS) and overlaid with
1% methyl cellulose in Dulbecco’s modified Eagle’s medium.
Virus plaques were counted at 48 h postinfection, and the
percentage of PFU surviving low-pH inactivation compared to
PBS-treated controls was calculated. The kinetics of ⌬gK
(gK⫺/⫺) virion entry was substantially reduced in comparison
to the KOS (gK⫹/⫹) strain. Furthermore, ⌬gK virions pro-

Downloaded from https://journals.asm.org/journal/jvi on 18 January 2022 by 2620:105:b001:1060:86f:667c:32f5:4ae9.

12436

NOTES

duced in the complementing cell line, VK302 (gK⫺/⫹), which is
transformed with the gK gene (18), entered substantially
faster, exhibiting entry kinetics similar to that of the KOS virus
(Fig. 5).
Considering the importance of gK in membrane fusion phenomena, it is not surprising that gK was found to be glycosylated by the Golgi apparatus as well as being a structural
component of the virion that functions to enhance virion entry.
In this regard, gK localizes where it is capable of participating
in multiple membrane fusion events during virion morphogenesis, virus-induced cell fusion, and virion penetration. ⌬gK
virions have a major defect in virion egress, which causes the
accumulation of virions within vesicles in the cytoplasm of
infected cells. The origin of these vesicles is not yet known;
however, morphological data suggest that they may be derived
from the Golgi complex. If this is true, it may mean that gK
functions in a Golgi complex-dependent pathway involved in
either reenvelopment at the Golgi complex according to the
deenvelopment/reenvelopment model (4, 13, 14, 40, 44) or
post-Golgi complex transport of virions to extracellular spaces.
It is important to note that lack of gK is not absolutely lethal
for virus replication in cell culture, although it does reduce
virus titers by more than 100-fold and substantially reduced the
kinetics of virus entry into Vero cells. Importantly, experimental infections in mice using the eye route indicate that gK may
be required for virus replication, spread, and neurovirulence in
vivo (unpublished data). Therefore, it is possible that the true
functions of gK may not be discernible in cell culture systems,
such as Vero cells, that have been selected for the optimum
replication of HSV virions. In this regard, more sensitive cell
culture systems and experimental animal studies may be required to delineate the functions of gK.
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